We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DISH
201
DELISTED
DISH Network Corp.
DISH
$673K 0.07%
37,562
+28,952
+336% +$702K
WMG icon
202
Warner Music
WMG
$13.8B
$672K 0.07%
+27,573
New +$823K
ARGX icon
203
argenx
ARGX
$54.1B
$665K 0.06%
+1,756
New +$566K
OSG
204
Octave Specialty Group
OSG
$222M
$659K 0.06%
+58,060
New +$551K
NKE icon
205
Nike
NKE
$61.9B
$659K 0.06%
6,445
+3,519
+120% +$416K
IDXX icon
206
Idexx Laboratories
IDXX
$46.2B
$658K 0.06%
+1,875
New +$765K
ARE icon
207
Alexandria Real Estate Equities
ARE
$8.56B
$657K 0.06%
+4,532
New +$769K
ARCH
208
DELISTED
Arch Resources, Inc.
ARCH
$655K 0.06%
+4,576
New +$728K
ENTA icon
209
Enanta Pharmaceuticals
ENTA
$400M
$654K 0.06%
+13,843
New +$751K
SLG icon
210
SL Green Realty
SLG
$3.99B
$652K 0.06%
14,124
– –
BIO icon
211
Bio-Rad Laboratories Class A
BIO
$9.42B
$647K 0.06%
1,307
+754
+136% +$393K
EIX icon
212
Edison International
EIX
$26.4B
$641K 0.06%
+10,139
New +$687K
YETI icon
213
Yeti Holdings
YETI
$3.95B
$641K 0.06%
14,825
– –
VSAT icon
214
Viasat
VSAT
$11.1B
$637K 0.06%
+20,805
New +$805K
CSX icon
215
CSX Corp
CSX
$93.1B
$635K 0.06%
+21,864
New +$713K
FAF icon
216
First American
FAF
$7.58B
$629K 0.06%
+11,889
New +$692K
ISRG icon
217
Intuitive Surgical
ISRG
$134B
$629K 0.06%
+3,133
New +$735K
RYTM icon
218
Rhythm Pharmaceuticals
RYTM
$7.96B
$628K 0.06%
151,213
+110,105
+268% +$603K
XNCR icon
219
Xencor
XNCR
$1.55B
$627K 0.06%
22,896
-5,276
-19% -$130K
BMY icon
220
Bristol-Myers Squibb
BMY
$132B
$622K 0.06%
+8,082
New +$616K
NWSA icon
221
News Corp Class A
NWSA
$15.4B
$620K 0.06%
+39,804
New +$732K
ALGN icon
222
Align Technology
ALGN
$12.3B
$619K 0.06%
2,616
+1,230
+89% +$378K
MANH icon
223
Manhattan Associates
MANH
$11.4B
$618K 0.06%
5,393
-393
-7% -$48.9K
ABT icon
224
Abbott
ABT
$187B
$616K 0.06%
+5,669
New +$644K
ANIK icon
225
Anika Therapeutics
ANIK
$287M
$609K 0.06%
+27,267
New +$608K
7 8
9
10 11

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.